Librede

About:

High Quality Pharmaceuticals from Yeast.

Website: http://www.librede.com/

Top Investors: National Science Foundation, National Center for Complementary and Integrative Health

Description:

Librede Inc. is a company that has a mission to improve the quality of life through innovated sustainable technologies. Librede focuses on the creation of platform technologies that enable the creation of new therapeutics; they use biology to build devices and manufacture molecules. They have developed the world’s first biosynthetic production platform that is targeting the endocannabinoid system.

Total Funding Amount:

$1.64M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2009-01-01

Founders:

Jacob Schmidt, Jason Poulos

Number of Employees:

1-10

Last Funding Date:

2018-02-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai